Pfizer / Credit: pio3/Shutterstock.com
The EU's antitrust authority reached its decision after the U.K. and U.S. companies agreed in June to divest Pfizer's ThermaCare pain therapy brand.
July 10, 2019 at 03:38 PM
1 minute read
The European Commission has cleared the way for the U.K.-based pharmaceutical giant GlaxoSmithKline to acquire the consumer health business of U.S.-based Pfizer, as long as it sells Pfizer’s pain management business.
The EU’s antitrust authority reached its decision after the U.K. and U.S. companies agreed in June to divest Pfizer’s ThermaCare pain therapy brand.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
